← Back to Search

Particle Therapy

Chemotherapy drug for Pancreatic Cancer

Phase 3

Waitlist Available

Led By Nitin Ohri, MD

Research Sponsored by Albert Einstein College of Medicine

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 24 months

Awards & highlights

Study Summary

This trial is testing a new kind of radiation therapy (carbon ion) to see if it's better than the standard care for pancreatic cancer.

Eligible Conditions

Pancreatic Cancer

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 24 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 24 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Overall survival duration

Secondary outcome measures

Adverse events as defined by CTCAE v5.0

Local disease progression scored using RECIST 1.1 criteria

Progression-free survival duration

+1 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Carbon ion radiotherapyExperimental Treatment2 Interventions

Carbon ion radiotherapy will be administered 5 days each week (Monday-Friday). The prescription dose will be 60 GyE in 20 fractions, to be delivered over four weeks.

Group II: Routine standard of careActive Control1 Intervention

Subjects on the control arm will not receive upfront radiotherapy but may receive radiotherapy (not carbon ion radiotherapy) if disease progression occurs.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Chemotherapy drug

2020

N/A

~70

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Albert Einstein College of MedicineLead Sponsor

286 Previous Clinical Trials

11,856,976 Total Patients Enrolled

Nitin OhriLead Sponsor

Shanghai Proton and Heavy Ion CenterOTHER

28 Previous Clinical Trials

2,235 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many people are included in this experiment?

"Based on the information available on clinicaltrials.gov, it seems that this study is still looking for participants. The first posting was on November 1st 2020 and the most recent update was January 14th 2022. They are hoping to find 137 individuals total from a single location."

Answered by AI

Are researchers looking for more participants at this time?

"That is correct, the listing on clinicaltrials.gov currently says that this study is looking for 137 patients at 1 location. The trial was first posted on November 1st, 2020 and last updated 14th January, 2022."

Answered by AI

What is the Chemotherapy drug's official government rating?

"There is some evidence from previous trials to support the efficacy of this chemotherapy drug, as well as data collected from multiple rounds of testing that suggest it is safe. For these reasons, our team has rated the safety of this drug a 3."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Carbon Ion RT for Locally Advanced Pancreatic Cancer

Nitin Ohri 2020. "Carbon Ion RT for Locally Advanced Pancreatic Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04592861.